Fajuan Cheng

727 total citations
33 papers, 561 citations indexed

About

Fajuan Cheng is a scholar working on Molecular Biology, Rheumatology and Immunology. According to data from OpenAlex, Fajuan Cheng has authored 33 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Rheumatology and 11 papers in Immunology. Recurrent topics in Fajuan Cheng's work include Systemic Lupus Erythematosus Research (10 papers), Epigenetics and DNA Methylation (6 papers) and Renal cell carcinoma treatment (5 papers). Fajuan Cheng is often cited by papers focused on Systemic Lupus Erythematosus Research (10 papers), Epigenetics and DNA Methylation (6 papers) and Renal cell carcinoma treatment (5 papers). Fajuan Cheng collaborates with scholars based in China, United States and Hong Kong. Fajuan Cheng's co-authors include Shu‐Feng Zhou, Hong Zhang, Ming‐Hui Zhao, Yuanyuan Qi, Ping Hou, Wei He, Zhigang Yao, Bin Zheng, Jianwei Wang and Zhihong Niu and has published in prestigious journals such as PLoS ONE, Scientific Reports and Annals of the Rheumatic Diseases.

In The Last Decade

Fajuan Cheng

32 papers receiving 557 citations

Peers

Countries citing papers authored by Fajuan Cheng

Since Specialization

Citations

This map shows the geographic impact of Fajuan Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fajuan Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fajuan Cheng more than expected).

Fields of papers citing papers by Fajuan Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fajuan Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fajuan Cheng. The network helps show where Fajuan Cheng may publish in the future.

Co-authorship network of co-authors of Fajuan Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Fajuan Cheng. A scholar is included among the top collaborators of Fajuan Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fajuan Cheng. Fajuan Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A prognostic signature based on genes associated with m6A/m5C/m1A/m7G modifications and its immunological characteristics in clear cell renal cell carcinoma 2024 ·Scientific Reports ·Wei He, Zixiang Cong, (unknown), Fajuan Cheng, T Yi, Zhigang Yao, Yiming Zhang, (unknown), (unknown), (unknown), Qiang Fu	2
2	The feasibility and safety of adopting the left lumbar vein to localize the renal artery location during left transperitoneal laparoscopic partial nephrectomy 2022 ·Frontiers in Surgery ·Zhigang Yao, (unknown), Bin Zheng, Zixiang Cong, Yiming Zhang, (unknown), Zhihong Niu, Fajuan Cheng, Wei He	1
3	Identification of New m6A Methylation Modification Patterns and Tumor Microenvironment Infiltration Landscape that Predict Clinical Outcomes for Papillary Renal Cell Carcinoma Patients 2022 ·Frontiers in Cell and Developmental Biology ·Bin Zheng, Fajuan Cheng, Zhigang Yao, Yiming Zhang, Zixiang Cong, Jianwei Wang, Zhihong Niu, Wei He	2
4	Effects and Safety of a Novel Oral Potassium-Lowering Drug-Sodium Zirconium Cyclosilicate for the Treatment of Hyperkalemia: a Systematic Review and Meta-Analysis 2021 ·Cardiovascular Drugs and Therapy ·Yaru Zhang, Ruiling Xu, Fanghao Wang, Youxia Liu, Junying Xu, Na Zhao, Fajuan Cheng, Li‐Hong Long, Junya Jia, Shan Lin	20
5	Integrative Analysis of Immune-Related Genes in the Tumor Microenvironment of Renal Clear Cell Carcinoma and Renal Papillary Cell Carcinoma 2021 ·Frontiers in Molecular Biosciences ·Bin Zheng, Fang Xie, Fajuan Cheng, Jianwei Wang, Zhigang Yao, Wei He, Zhihong Niu	8
6	The Roles of CircRNAs in Bladder Cancer: Biomarkers, Tumorigenesis Drivers, and Therapeutic Targets 2021 ·Frontiers in Cell and Developmental Biology ·Fajuan Cheng, Bin Zheng, (unknown), Jianwei Wang, (unknown), Zhigang Yao, Zhihong Niu, Wei He	13
7	NUPR1 is a novel potential biomarker and confers resistance to sorafenib in clear cell renal cell carcinoma by increasing stemness and targeting the PTEN/AKT/mTOR pathway 2021 ·Aging ·Wei He, Fajuan Cheng, Bin Zheng, Jianwei Wang, (unknown), Zhigang Yao, Tong Zhang	15
8	Thymol alleviates lipopolysaccharide-stimulated inflammatory response via downregulation of RhoA-mediated NF-κB signalling pathway in human peritoneal mesothelial cells 2018 ·European Journal of Pharmacology ·Qinglian Wang, Fajuan Cheng, Ying Xu, Jing Zhang, Jianjun Qi, Xiang Liu, Rong Wang	32
9	Increased autophagy is cytoprotective against podocyte injury induced by antibody and interferon-α in lupus nephritis 2018 ·Annals of the Rheumatic Diseases ·Yuanyuan Qi, Shu‐Feng Zhou, Fajuan Cheng, Ping Hou, Yali Ren, Suxia Wang, Ming‐Hui Zhao, Li Yang, Jennifer Martinez, Hong Zhang	86
10	Autophagy-related gene LRRK2 is likely a susceptibility gene for systemic lupus erythematosus in northern Han Chinese 2017 ·Oncotarget ·Yuemiao Zhang, Shu‐Feng Zhou, Fajuan Cheng, Yuanyuan Qi, Ping Hou, Ming‐Hui Zhao, Hong Zhang	22
11	Polymorphism rs3828903 withinMICBIs Associated with Susceptibility to Systemic Lupus Erythematosus in a Northern Han Chinese Population 2016 ·Journal of Immunology Research ·Yuemiao Zhang, Shu‐Feng Zhou, Fajuan Cheng, Yuanyuan Qi, Ping Hou, Ming‐Hui Zhao, Hong Zhang	5
12	Elevated Plasmaα-Defensins (HNP1–3) Levels Correlated with IgA1 Glycosylation and Susceptibility to IgA Nephropathy 2016 ·Disease Markers ·Yuanyuan Qi, Shu‐Feng Zhou, Fajuan Cheng, Hong Zhang	6
13	DEFA gene variants associated with IgA nephropathy in a Chinese population 2015 ·Genes and Immunity ·(unknown), Shu‐Feng Zhou, Fajuan Cheng, Ping Hou, Li Zhu, Sufang Shi, (unknown), Jicheng Lv, Hong Zhang	14
14	Rare Variants of ATG5 Are Likely to Be Associated With Chinese Patients With Systemic Lupus Erythematosus 2015 ·Medicine ·Yuemiao Zhang, Fajuan Cheng, Shu‐Feng Zhou, Yuanyuan Qi, Minghui Zhao, Hong Zhang	16
15	Association of Systemic Lupus Erythematosus Susceptibility Genes with IgA Nephropathy in a Chinese Cohort 2014 ·Clinical Journal of the American Society of Nephrology ·Shu‐Feng Zhou, Fajuan Cheng, Li Zhu, Jicheng Lv, Yuanyuan Qi, Ping Hou, Hong Zhang	27
16	Chemokine receptor 5 (CCR5) delta 32 polymorphism in lupus nephritis: A large case-control study and meta-analysis 2014 ·Autoimmunity ·Fajuan Cheng, Shu‐Feng Zhou, Yanfeng Zhao, Ming‐Hui Zhao, Hong Zhang	6
17	Emerging View of Autophagy in Systemic Lupus Erythematosus 2014 ·International Reviews of Immunology ·Shu‐Feng Zhou, Fajuan Cheng, Hong Zhang	21
18	Alpha-defensin DEFA1A3 gene copy number variation in Asians and its genetic association study in Chinese systemic lupus erythematosus patients 2013 ·Gene ·Fajuan Cheng, Shu‐Feng Zhou, Yanfeng Zhao, Ming‐Hui Zhao, Hong Zhang	12
19	FCGR2B and FCRLB Gene Polymorphisms Associated with IgA Nephropathy 2013 ·PLoS ONE ·Shu‐Feng Zhou, Fajuan Cheng, Yuanyuan Qi, Yanfeng Zhao, Ping Hou, Li Zhu, Jicheng Lv, Hong Zhang	23
20	Higher DEFB4 genomic copy number in SLE and ANCA-associated small vasculitis 2012 ·Lara D. Veeken ·Shu‐Feng Zhou, Fajuan Cheng, Jicheng Lv, Huan Luo, Feng Yu, Min Chen, Ming‐Hui Zhao, Hong Zhang	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact